Related references
Note: Only part of the references are listed.Interactions between the gut microbiome and host gene regulation in cystic fibrosis
Gargi Dayama et al.
GENOME MEDICINE (2020)
CFTR dysregulation drives active selection of the gut microbiome
Stacey M. Meeker et al.
PLOS PATHOGENS (2020)
The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases
Dapeng Zhang et al.
FRONTIERS IN MICROBIOLOGY (2020)
A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease
Wikrom Karnsakul et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment
Maartje Kristensen et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
The intestinal virome in children with cystic fibrosis differs from healthy controls
Michael J. Coffey et al.
PLOS ONE (2020)
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
Michal Shteinberg et al.
EUROPEAN RESPIRATORY REVIEW (2020)
Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis
Brett R. Loman et al.
PEDIATRIC PULMONOLOGY (2020)
Real-world effectiveness of ivacaftor in children with cystic fibrosis and the G551D mutation
David Gomez-Pastrana et al.
ANALES DE PEDIATRIA (2019)
IVACAFTOR restores FGF19 regulated bile acid homeostasis in cystic fibrosis patients with an S1251N or a G551D gating mutation
Ivo P. van de Peppel et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Systematic Review of Probiotics for Cystic Fibrosis Patients: Moving Forward
Lenycia de Cassya Lopes Neri et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB)
Margaret Rosenfeld et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Time for a gut check: Pancreatic sufficiency resulting from CFTR modulator use
Rosemary Megalaa et al.
PEDIATRIC PULMONOLOGY (2019)
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2-5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study
John McNamara et al.
LANCET RESPIRATORY MEDICINE (2019)
A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11 years with cystic fibrosis
Seth Walker et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Pancreatic insufficiency converted to pancreatic sufficiency with ivacaftor
Jennifer L. Hamilton et al.
PEDIATRIC PULMONOLOGY (2019)
Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis
Venkata S. Akshintala et al.
PANCREATOLOGY (2019)
Modifier genes in cystic fibrosis-related liver disease
Dominique Debray et al.
CURRENT OPINION IN GASTROENTEROLOGY (2019)
Decreased Fecal Calprotectin Levels in Cystic Fibrosis Patients After Antibiotic Treatment for Respiratory Exacerbation
Zeev Schnapp et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)
Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis
Michael J. Coffey et al.
SCIENTIFIC REPORTS (2019)
Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients
Katherine Kutney et al.
WORLD JOURNAL OF HEPATOLOGY (2019)
Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
Mansi Kanhere et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Long-term intestinal obstruction sequelae and growth in children with cystic fibrosis operated for meconium ileus: expectancies and surprises4
Anastasia Mentessidou et al.
JOURNAL OF PEDIATRIC SURGERY (2018)
Pancreatic Insufficiency in Cystic Fibrosis: Influence of Inflammatory Response Genes
Fernando Augusto Lima Marson et al.
PANCREAS (2018)
Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis
Rohini R. Vanga et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Disease-modifying genetic factors in cystic fibrosis
Fernando A. L. Marson
CURRENT OPINION IN PULMONARY MEDICINE (2018)
Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
Andrea Gini et al.
GASTROENTEROLOGY (2018)
Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations
Denis Hadjiliadis et al.
GASTROENTEROLOGY (2018)
Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis With Ivacaftor: Case Series
Andres Carrion et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
Energy Balance and Mechanisms of Weight Gain with Ivacaftor Treatment of Cystic Fibrosis Gating Mutations
Virginia A. Stallings et al.
JOURNAL OF PEDIATRICS (2018)
Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis
Akihiro Yamada et al.
LANCET ONCOLOGY (2018)
Use and Incidence of Adverse Effects of Proton Pump Inhibitors in Patients with Cystic Fibrosis
Bradley E. McCrory et al.
PHARMACOTHERAPY (2018)
Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis
Maiara Brusco de Freitas et al.
PLOS ONE (2018)
Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study
Margaret Rosenfeld et al.
LANCET RESPIRATORY MEDICINE (2018)
Cystic fibrosis survival: the changing epidemiology
Sophie Corriveau et al.
CURRENT OPINION IN PULMONARY MEDICINE (2018)
Associations between Flavonoid Intakes and Gut Microbiota in a Group of Adults with Cystic Fibrosis
Li Li et al.
NUTRIENTS (2018)
Diet, Microbiota and Gut-Lung Connection
Swadha Anand et al.
FRONTIERS IN MICROBIOLOGY (2018)
Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype
Pamela Vernocchi et al.
PLOS ONE (2018)
Evaluation of noninvasive markers for the diagnosis of cystic fibrosis liver disease
Alexandra Alexopoulou et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation
Chee Y. Ooi et al.
SCIENTIFIC REPORTS (2018)
Cystic Fibrosis and gastroesophageal reflux disease
Asim Maqbool et al.
Journal of Cystic Fibrosis (2017)
Meconium ileus in Cystic Fibrosis
Meghana Sathe et al.
Journal of Cystic Fibrosis (2017)
Pancreatitis and pancreatic cystosis in Cystic Fibrosis
A. Jay Freeman et al.
Journal of Cystic Fibrosis (2017)
Cystic Fibrosis-related cirrhosis
Daniel H. Leung et al.
Journal of Cystic Fibrosis (2017)
Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation
Gemma L. Zeybel et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
Does probiotic supplementation affect pulmonary exacerbation and intestinal inflammation in cystic fibrosis: a systematic review of randomized clinical trials
Zeinab Nikniaz et al.
WORLD JOURNAL OF PEDIATRICS (2017)
A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics
Pamela Vernocchi et al.
NUTRIENTS (2017)
Proton Pump Inhibitor Use Is Associated With an Increased Frequency of Hospitalization in Patients With Cystic Fibrosis
Fares Ayoub et al.
GASTROENTEROLOGY RESEARCH (2017)
Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota
Francesco Miragoli et al.
FEMS MICROBIOLOGY ECOLOGY (2017)
The altered gut microbiota in adults with cystic fibrosis
D. G. Burke et al.
BMC MICROBIOLOGY (2017)
Pancreatic pathophysiology in cystic fibrosis
Katherine N. Gibson-Corley et al.
JOURNAL OF PATHOLOGY (2016)
Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis
Jaclyn R. Stonebraker et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis
Dominique Turck et al.
CLINICAL NUTRITION (2016)
International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome
Anne Munck et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
Morphological and Functional Assessment of Oesophageal Mucosa Integrity in Children With Cystic Fibrosis
Jernej Brecelj et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2016)
Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis
Shaun Nielsen et al.
SCIENTIFIC REPORTS (2016)
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study
Jane C. Davies et al.
LANCET RESPIRATORY MEDICINE (2016)
Emerging role of cystic fibrosis transmembrane conductance regulator - an epithelial chloride channel in gastrointestinal cancers
Yuning Hou et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease
Daniel H. Leung et al.
HEPATOLOGY (2015)
Improvement of Hepatic Steatosis in Cystic Fibrosis With Ivacaftor Therapy
Don Hayes et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2015)
Cystic fibrosis: An update for clinicians. Part 1: Nutrition and gastrointestinal complications
Wolfram Haller et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
Emily DiMango et al.
BMC PULMONARY MEDICINE (2014)
Eosinophilic esophagitis in cystic fibrosis: A case series and review of the literature
Jennifer L. Goralski et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
The Role of Endoscopy and Biopsy in the Management of Severe Gastrointestinal Disease in Cystic Fibrosis Patients
Neil Shah et al.
PEDIATRIC PULMONOLOGY (2013)
Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease
Dominique Debray et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Defining DIOS and Constipation in Cystic Fibrosis With a Multicentre Study on the Incidence, Characteristics, and Treatment of DIOS
Roderick H. Houwen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2010)
Outcomes of fundoplication in children with cystic fibrosis
R. Pau Boesch et al.
JOURNAL OF PEDIATRIC SURGERY (2007)
Patterns of GI disease in adulthood associated with mutations in the CFTR gene
Michael Wilschanski et al.
GUT (2007)
Review of the abdominal manifestations of cystic fibrosis in the adult patient
Michael B. Robertson et al.
RADIOGRAPHICS (2006)
Abdominal manifestations of cystic fibrosis in children
G Chaudry et al.
PEDIATRIC RADIOLOGY (2006)
Fibrosing colonopathy in an adult cystic fibrosis patient after discontinuing pancreatic enzyme therapy
EH Mack et al.
SOUTHERN MEDICAL JOURNAL (2004)
Fibrosing colonopathy revealing cystic fibrosis in a neonate before any pancreatic enzyme supplementation
DE Serban et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2002)
Colonic disorders in adult cystic fibrosis
H Chaun
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Share Paper
